The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice.
The Role of Pancreatic Preproglucagon in Glucose Homeostasis in Mice.
复制标题
DOI:
10.1016/j.cmet.2017.02.008
复制
发表时间:
2017-04-04
期刊:
影响因子:
29
通讯作者:
Sandoval DA
中科院分区:
文献类型:
--
作者:
Chambers AP;Sorrell JE;Haller A;Roelofs K;Hutch CR;Kim KS;Gutierrez-Aguilar R;Li B;Drucker DJ;D'Alessio DA;Seeley RJ;Sandoval DA
Glucagon-like peptide 1 (GLP-1) is necessary for normal gluco-regulation, and it has been widely presumed that this function reflects the actions of GLP-1 released from enteroendocrine L-cells. To test the relative importance of intestinal vs. pancreatic sources of GLP-1 for physiological regulation of glucose, we administered a GLP-1R antagonist, exendin 9–39 (Ex9), to mice with tissue-specific reactivation of the preproglucagon gene (Gcg). Ex9 impaired glucose tolerance in wild-type mice but had no impact on Gcg null or GLP-1R KO mice suggesting that Ex9 is a true and specific GLP-1R antagonist. Unexpectedly, Ex-9 had no effect on blood glucose in mice with restoration of intestinal Gcg. In contrast, pancreatic reactivation of Gcg fully restored the effect of Ex9 to impair both oral and IP glucose tolerance. These findings suggest an alternative model whereby islet GLP-1 also plays an important role in regulating glucose homeostasis. GLP-1 is necessary for normal gluco-regulation, and it has been widely presumed that this function is the action of peptide released from enteroendocrine L-cells. The data from Chambers et al. challenge this dogma and find that intestinally produced GLP-1 is dispensable while pancreatic production of GLP-1 is necessary for gluco-regulation.